Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:00 PM
Ignite Modification Date:
2025-12-24 @ 7:00 PM
NCT ID:
NCT03816657
Eligibility Criteria:
Inclusion Criteria:
* Patients with histologic diagnosis of advanced NSCLC who received Nivolumab as second or further line of therapy
* Paraffin-embedded tissue sample available for PD-L1 analysis
* disponibilità di emocromo entro 4 settimane dall'inizio del trattamento con Nivolumab
* To calculate NLR, the absolute neutrophil count was divided by the lymphocytes value measured in peripheral blood within 4 weeks prior to the first infusion of nivolumab.
No main Exclusion Criteria
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT03816657
Study Brief:
Protocol Section:
NCT03816657